Abstract P6-21-01, Xentuzumab (BI 836845), an insulin-like growth factor (IGF)-neutralizing antibody (Ab), combined with exemestane and everolimus in hormone receptor-positive (HR+) locally advanced/metastatic breast cancer (LA/mBC): Randomized phase 2 re
Funny thing about having kids is I find myself measuring life in their birthdays more than my own
Do: Tell Your Doctor About Other Medications Youre Taking Before you start taking a beta-blocker, share with your doctor a complete list of every medication and dietary supplement youre taking
We urge you to consult with a functional medicine practice to ensure that youre receiving comprehensive treatment
Monique Ramsey (00:33): Yeah
Learn More Hyperhidrosis Sweating Treatments Effectively reduce excessive sweating in areas like the underarms, face, or palms with targeted injections